期刊
JOURNAL OF CLINICAL PATHOLOGY
卷 64, 期 8, 页码 649-653出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/jcp.2011.089847
关键词
-
类别
资金
- Roche Products Ltd, Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire
These guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据